NuVasive, Inc. (NUVA) Misses Q3 EPS by 6c; Bumps FY Outlook by a Penny

NuVasive, Inc. (NASDAQ: NUVA) reported Q3 EPS of $0.19, $0.06 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $189.9 million versus the consensus estimate of $179.3 million.

NuVasive, Inc. sees FY2014 EPS of $1.12, versus prior guidance of $1.11 and the consensus of $1.12. NuVasive, Inc. sees FY2014 revenue of $755 million.

"We are pleased to report results for the third quarter 2014 that exceeded revenue expectations, generated record free cash flow and demonstrated strong progress toward our commitment to increase operating profitability," said Alex Lukianov, Chairman and Chief Executive Officer of NuVasive. "Last quarter we announced our position as the #3 spine player globally. That is an incredible accomplishment for the entire NUVA family and we are proud that our strategy delivered continued market share gains in the third quarter. We are laser focused on delivering on our updated full year performance expectations with a strong finish to 2014. The combination of our dynamic share taking strategy with our well-defined levers for improving profitability is set to drive our growth this year and improve shareholder value over the next several years."

For earnings history and earnings-related data on NuVasive, Inc. (NUVA) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Equity Residential (EQR) Tops Q1 EPS by 44c; offers guidance
• Baker Hughes Company (BKR) Tops Q1 EPS by 4c, Beats on Revenue